However, the prognostically significant genes in the guadecitabine signature were upregulated by this DNMT inhibitor in melanoma cells, while the prognostically significant genes in the JQ1 signature were frequently downregulated by the BET inhibitor in melanoma cells (Suppl. The gene discussed is DNER; the disease is melanoma.